hrcak mascot   Srce   HID

Professional paper

Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.

Eftychia Platsidaki ; MD
Evgenia Balamoti ; MD
Anargyros Kouris ; PhD
Alexandra Katsarou ; MD
Nikolaos Mylonakis ; MD
Charitomeni Vavouli ; MD
Georgios Kontochristopoulos ; PhD

Fulltext: english, PDF (124 KB) pages 245-245 downloads: 301* cite
APA 6th Edition
Platsidaki, E., Balamoti, E., Kouris, A., Katsarou, A., Mylonakis, N., Vavouli, C. & Kontochristopoulos, G. (2017). Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.. Acta Dermatovenerologica Croatica, 25 (3), 245-245. Retrieved from https://hrcak.srce.hr/187822
MLA 8th Edition
Platsidaki, Eftychia, et al. "Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.." Acta Dermatovenerologica Croatica, vol. 25, no. 3, 2017, pp. 245-245. https://hrcak.srce.hr/187822. Accessed 6 Dec. 2021.
Chicago 17th Edition
Platsidaki, Eftychia, Evgenia Balamoti, Anargyros Kouris, Alexandra Katsarou, Nikolaos Mylonakis, Charitomeni Vavouli and Georgios Kontochristopoulos. "Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.." Acta Dermatovenerologica Croatica 25, no. 3 (2017): 245-245. https://hrcak.srce.hr/187822
Harvard
Platsidaki, E., et al. (2017). 'Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.', Acta Dermatovenerologica Croatica, 25(3), pp. 245-245. Available at: https://hrcak.srce.hr/187822 (Accessed 06 December 2021)
Vancouver
Platsidaki E, Balamoti E, Kouris A, Katsarou A, Mylonakis N, Vavouli C, et al. Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.. Acta Dermatovenerol Croat. [Internet]. 2017 [cited 2021 December 06];25(3):245-245. Available from: https://hrcak.srce.hr/187822
IEEE
E. Platsidaki, et al., "Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.", Acta Dermatovenerologica Croatica, vol.25, no. 3, pp. 245-245, 2017. [Online]. Available: https://hrcak.srce.hr/187822. [Accessed: 06 December 2021]

Abstracts

Bevacizumab is a humanized monoclonal antibody against vascular endothelial factor (VEGF) that targets tumor cell angiogenesis and proliferation. Although it is usually well tolerated, many side-effects have been reported. These include hypertension, bleeding, and thromboembolic events among others. Drug-associated cutaneous adverse effects are less common and include itching, exfoliative dermatitis, and acneiform eruptions. A man with bevacizumab-associated monomorphic skin eruption successfully was treated with 30% salicylic acid peels. To the author’s knowledge, this is the first report of open comedones with no further inflammatory acne lesions that developed in a patient treated with bevacizumab. Complete remission of the rash was achieved after performing 30% salicylic peels, and the patient continued the chemotherapy as planned with no need of either dose reduction or discontinuation of bevacizumab.

 

Hrčak ID: 187822

URI
https://hrcak.srce.hr/187822

Visits: 455 *